Laura Rodón

1.2k total citations
12 papers, 552 citations indexed

About

Laura Rodón is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Laura Rodón has authored 12 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Laura Rodón's work include Ubiquitin and proteasome pathways (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer-related Molecular Pathways (3 papers). Laura Rodón is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer-related Molecular Pathways (3 papers). Laura Rodón collaborates with scholars based in United States, Spain and United Kingdom. Laura Rodón's co-authors include Joan Seoane, Alba Gonzàlez-Juncà, Elena Martínez‐Sáez, Pieter J.A. Eichhorn, José Baselga, Juan Sahuquillo, José Jiménez, Annette M.G. Dirac, René Bernards and David García‐Dorado and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Laura Rodón

12 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Rodón United States 6 447 212 109 67 47 12 552
Carrie R. Graveel United States 11 419 0.9× 201 0.9× 110 1.0× 86 1.3× 52 1.1× 21 635
Azadeh Arabi Iran 11 672 1.5× 193 0.9× 123 1.1× 55 0.8× 59 1.3× 14 795
Ralitsa R. Madsen United Kingdom 11 280 0.6× 103 0.5× 104 1.0× 55 0.8× 46 1.0× 18 499
Nicolás Herranz Spain 7 614 1.4× 251 1.2× 158 1.4× 58 0.9× 35 0.7× 10 790
Alba Gonzàlez-Juncà United States 8 527 1.2× 253 1.2× 141 1.3× 35 0.5× 61 1.3× 13 697
Xiangshu Jin China 12 262 0.6× 119 0.6× 154 1.4× 91 1.4× 40 0.9× 37 556
M. Ángeles Villaronga Spain 17 420 0.9× 139 0.7× 162 1.5× 74 1.1× 40 0.9× 28 577
Jason P. Frazier United States 7 397 0.9× 160 0.8× 94 0.9× 50 0.7× 42 0.9× 12 500
Shuet Theng Lee Singapore 5 576 1.3× 173 0.8× 216 2.0× 67 1.0× 45 1.0× 5 715
Kathryn M. Kinross Australia 9 409 0.9× 158 0.7× 88 0.8× 77 1.1× 100 2.1× 16 632

Countries citing papers authored by Laura Rodón

Since Specialization
Citations

This map shows the geographic impact of Laura Rodón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Rodón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Rodón more than expected).

Fields of papers citing papers by Laura Rodón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Rodón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Rodón. The network helps show where Laura Rodón may publish in the future.

Co-authorship network of co-authors of Laura Rodón

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Rodón. A scholar is included among the top collaborators of Laura Rodón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Rodón. Laura Rodón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Lee, Nathan V., Wei Deng, Dayong Zhai, et al.. (2021). Abstract 1104: Repotrectinib increases effectiveness of MEK inhibitors in KRAS mutant cancer models. Cancer Research. 81(13_Supplement). 1104–1104. 1 indexed citations
2.
Zhai, Dayong, et al.. (2020). Abstract 1958: Repotrectinib increases effectiveness of KRAS-G12C inhibitors in KRAS-G12C mutant cancer models via simultaneous SRC/FAK/JAK2 inhibition. Cancer Research. 80(16_Supplement). 1958–1958. 1 indexed citations
3.
Murray, Brion W., Wei Deng, Dayong Zhai, et al.. (2020). Abstract 1957: Repotrectinib increases effectiveness of MEK inhibitor trametinib in KRAS mutant cancer models via simultaneous SRC/FAK/JAK2 inhibition. Cancer Research. 80(16_Supplement). 1957–1957. 2 indexed citations
4.
Drilon, Alexander, Dayong Zhai, Evan Rogers, et al.. (2020). The next-generation RET inhibitor TPX-0046 is active in drug-resistant and naïve RET-driven cancer models.. Journal of Clinical Oncology. 38(15_suppl). 3616–3616. 45 indexed citations
5.
Tasoulas, Jason, Laura Rodón, Frederic J. Kaye, Marc Montminy, & Antonio L. Amelio. (2019). Adaptive Transcriptional Responses by CRTC Coactivators in Cancer. Trends in cancer. 5(2). 111–127. 18 indexed citations
6.
Rodón, Laura, Robert Svensson, Ezra Wiater, et al.. (2019). The CREB coactivator CRTC2 promotes oncogenesis in LKB1-mutant non–small cell lung cancer. Science Advances. 5(7). eaaw6455–eaaw6455. 33 indexed citations
7.
Iyengar, Prasanna Vasudevan, Patrick Jaynes, Laura Rodón, et al.. (2015). USP15 regulates SMURF2 kinetics through C-lobe mediated deubiquitination. Scientific Reports. 5(1). 14733–14733. 43 indexed citations
8.
Rodón, Laura, Alba Gonzàlez-Juncà, María del Mar Inda, et al.. (2014). Active CREB1 Promotes a Malignant TGFβ2 Autocrine Loop in Glioblastoma. Cancer Discovery. 4(10). 1230–1241. 68 indexed citations
9.
Rodón, Laura & Joan Seoane. (2012). 400 CREB Regulates the Autocrine Induction of TGF-52 by TGF-b in Glioblastoma. European Journal of Cancer. 48. S97–S97. 1 indexed citations
10.
Eichhorn, Pieter J.A., Laura Rodón, Alba Gonzàlez-Juncà, José Baselga, & Joan Seoane. (2012). Abstract LB-31: USP15 stabilizes the TGF-β receptor I and promotes oncogenesis through the activation of the TGF-β signal in glioblastoma. Cancer Research. 72(8_Supplement). LB–31. 3 indexed citations
11.
Eichhorn, Pieter J.A., Laura Rodón, Alba Gonzàlez-Juncà, et al.. (2012). USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma. Nature Medicine. 18(3). 429–435. 332 indexed citations
12.
Anido, Judit, Andrea Sáez‐Borderías, Alba Gonzàlez-Juncà, et al.. (2010). Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. 18(6). 655–668. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carrie R. Graveel Breakdown of academic impact, for papers by Azadeh Arabi Breakdown of academic impact, for papers by Ralitsa R. Madsen Breakdown of academic impact, for papers by Nicolás Herranz Breakdown of academic impact, for papers by Alba Gonzàlez-Juncà Breakdown of academic impact, for papers by Xiangshu Jin Breakdown of academic impact, for papers by M. Ángeles Villaronga Breakdown of academic impact, for papers by Jason P. Frazier Breakdown of academic impact, for papers by Shuet Theng Lee Breakdown of academic impact, for papers by Kathryn M. Kinross
Rankless by CCL
2026